LQCCUVFFZFOPOO-CLRCNGAQSA-N
C25H28F3N4O8P — CID 162596176
Data last refreshed: (MolForge compound catalog, from PubChem)
About LQCCUVFFZFOPOO-CLRCNGAQSA-N
LQCCUVFFZFOPOO-CLRCNGAQSA-N (PubChem CID 162596176) has the molecular formula C25H28F3N4O8P and a molecular weight of 600.49 g/mol. Its IUPAC name is propan-2-yl (2S)-2-[[[(2R,3R,5R)-5-(4-amino-5-fluoro-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-naphthalen-2-yloxyphosphoryl]amino]propanoate.
Molecular Properties
| Compound Name | LQCCUVFFZFOPOO-CLRCNGAQSA-N |
|---|---|
| PubChem CID | 162596176 |
| Molecular Formula | C25H28F3N4O8P |
| Molecular Weight | 600.49 g/mol |
| Exact Mass | 600.16 |
| IUPAC Name | propan-2-yl (2S)-2-[[[(2R,3R,5R)-5-(4-amino-5-fluoro-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-naphthalen-2-yloxyphosphoryl]amino]propanoate |
| SMILES | CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccc2ccccc2c1 |
| InChI | InChI=1S/C25H28F3N4O8P/c1-13(2)38-22(34)14(3)31-41(36,40-17-9-8-15-6-4-5-7-16(15)10-17)37-12-19-20(33)25(27,28)23(39-19)32-11-18(26)21(29)30-24(32)35/h4-11,13-14,19-20,23,33H,12H2,1-3H3,(H,31,36)(H2,29,30,35)/t14-,19+,20+,23+,41?/m0/s1 |
| InChIKey | LQCCUVFFZFOPOO-CLRCNGAQSA-N |
| XLogP | 3.14 |
| TPSA | 164.23 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 600.49 |
| LogP ≤ 5 | 3.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162596176 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.